SD5

5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine

Created:2011-06-14
Last modified:  2011-06-14
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count50
Chiral Atom Count0
Bond Count53
Aromatic Bond Count12
2D diagram of SD5
Chemical Component Summary
Name5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine
Systematic Name (OpenEye OEToolkits)5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
FormulaC18 H21 F3 N6 O2
Molecular Weight410.394
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESACDLabs12.01FC(F)(F)c1cc(ncc1c3nc(nc(N2CCOCC2)c3)N4CCOCC4)N
SMILESCACTVS3.370Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
SMILESOpenEye OEToolkits1.7.2c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
Canonical SMILESCACTVS3.370 Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
Canonical SMILESOpenEye OEToolkits1.7.2 c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
InChIInChI1.03 InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)
InChIKeyInChI1.03 CWHUFRVAEUJCEF-UHFFFAOYSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB11666 
NameBuparlisib
Groups investigational
DescriptionBuparlisib has been used in trials studying the treatment and basic science of Lymphoma, Metastases, Lung Cancer, Solid Tumors, and Breast Cancer, among others.
Synonyms
  • Buparlisibum
  • Buparlisib hydrochloride
  • Buparlisib
Categories
  • Amines
  • Oxazines
  • Phosphatidylinositol 3-Kinases, antagonists & inhibitors
  • Pyridines
CAS number944396-07-0

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformMPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELF...unknowninhibitor
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformMCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREA...unknowninhibitor
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformMELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRK...unknowninhibitor
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformMPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLW...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL2017974
PubChem 16654980
ChEMBL CHEMBL2017974
ChEBI CHEBI:71954